85550 Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Board 

on Medical Rehabilitation Research. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. 

Individuals who plan to attend inperson or view the virtual meeting and 

need special assistance or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

can be accessed from the NIH Videocast 

at the following link: https://

videocast.nih.gov/. 

Name of Committee: National Advisory 

Board on Medical Rehabilitation Research. 

Date: December 2–3, 2024. 

Time: December 02, 2024, 10:00 a.m. to 

5:00 p.m. 

Agenda: NICHD Director’s Report, NCMRR 

Director’s report; NABMRR Liaison to NICHD 

Advisory Council Report; Scientific Talk on 

Collaboration; Report from the NIH Disability 

Research Coordinating Committee; Scientific 

Talk on Bilateral Task Training Post Stroke; 

Updates on the NIH Research Plan on 

Rehabilitation; Nominations for next Chair. 

Address: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, 6710B Rockledge Drive, 

Bethesda, MD 20817 (In Person and Virtual 

Meeting). 

Time: December 03, 2024, 10:00 a.m. to 

2:00 p.m. 

Agenda: Implementation of the NIH’s 

Simplified Review Framework; Scientific 

Talk on BCI; Election of Chair; Talk on 

Community Engagement in Research; 

Planning for next meeting in May 2025. 

Address: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, 6710B Rockledge Drive, 

Bethesda, MD 20817 (In Person and Virtual 

Meeting). 

Contact Person: Ralph M. Nitkin, Ph.D., 

Deputy Director, National Center for Medical 

Rehabilitation, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6710B Rockledge 

Drive, Room 2116, Bethesda, MD 20892– 

7510, (301) 402–4206, nitkinr@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Persons listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of an organization may 

submit a letter of intent, a brief description 

of the organization represented and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and 

presentations may be limited to five minutes. 

Both printed and electronic copies are 

requested for the record. In addition, any 

interested person may file written comments 

with the committee by forwarding the 

statement to the Contact Person listed on this 

notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nichd.nih.gov/about/advisory/nabmrr, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: October 22, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–24982 Filed 10–25–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention’s 

(CSAP) Drug Testing Advisory Board 

(DTAB) will convene via web 

conference on December 3, 2024, from 

10 a.m. EST to 2:30 p.m. EST. 

The board will meet in open session 

December 3, 2024, from 10 a.m. EST to 

2:30 p.m. EST to hear updates from the 

Department of Transportation (DOT), 

the Department of Defense (DoD) and 

the Nuclear Regulatory Commission 

(NRC), and updates from HHS on the 

Federal Workplace Drug Testing 

Program and Mandatory Guidelines. 

Additionally, the board will hear 

presentations regarding a collaboration 

between the Department of Defense and 

the Division of Workplace Programs as 

well as data presented for consideration 

regarding evaluation of the cutoff for an 

invalid pH result in urine. 

Data provided by HHS-certified 

laboratories indicates that invalid urine 

pH results cycle with the seasonal 

temperature fluctuations. Data will be 

presented to facilitate and inform 

decisions regarding a possible 

adjustment in the cutoff for urine pH to 

reduce this cyclical effect while 

continuing to identify potential 

tampering of specimens. 

Meeting registration information can 

be completed at https://

snacregister.samhsa.gov/. Web 

conference and call information will be 

sent after completing registration. 

Meeting information and a roster of 

DTAB members may be obtained by 

accessing the SAMHSA Advisory 

Committees website, https://

www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting the 

Designated Federal Officer, Lisa Davis. 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration, Center for Substance 

Abuse Prevention, Drug Testing 

Advisory Board. 

Dates/Time/Type: December 3, 2024, 

from 10:00am EST to 2:30pm EST: 

Open. 

Place: Virtual. 

To Submit Comments: Requests to 

make public comment during the public 

comment period of the December DTAB 

meeting must be made in writing at least 

7 days prior to the meeting to the 

following email: DFWP@

samhsa.hhs.gov. 

Contact: Lisa S. Davis, M.S, Social 

Science Analyst, Center for Substance 

Abuse Prevention, 5600 Fishers Lane, 

Rockville, Maryland, 20857, Telephone: 

(240) 276–1440, Email: Lisa.Davis@

samhsa.hhs.gov. 

Anastasia Flanagan, 

Public Health Advisor, Division of Workplace 

Programs. 

[FR Doc. 2024–24972 Filed 10–25–24; 8:45 am] 

BILLING CODE 4162–20–P 


lotter on DSK11XQN23PROD with NOTICES1